Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions-Reference-Cited by-同舟云学术

Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions

Published:2020-02 Issue: Volume:301 Page:50-55
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Carrié Didier,Berland Jacques,Verheye Stefan,Hauptmann Karl Eugen,Vrolix Mathias,Musto Carmine,Berti Sergio,Dibié Alain,Maupas Eric,Antoniucci David,Schofer Joachim

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries);Lee;Am. J. Cardiol.,2014

2. Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions;Ormiston;Coron. Artery Dis.,2013

3. Everolimus-eluting Xience V/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus;Park;JACC Cardiovasc. Interv.,2014

4. Coronary artery revascularization in patients with diabetes mellitus;Armstrong;Circulation,2013

5. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial;Kappetein;Eur. J. Cardiothorac. Surg.,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI;American Heart Journal;2023-11

2. Long‐term follow‐up of contemporary drug‐eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial;Catheterization and Cardiovascular Interventions;2023-01-18

3. Meta-Analysis of Randomized Controlled Trials Evaluating the Efficacy of Polymer-Free Amphilimus-Eluting Stents in Coronary Artery Disease;The American Journal of Cardiology;2022-03

4. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial;European Heart Journal;2021-11-04

5. 3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent;JACC: Cardiovascular Interventions;2021-11